InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Duhay Francis, Director. Officer active across 2 companies, notably Hancock Jaffe Laboratories, Inc.. Cumulatively, 4 disclosures have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €370k. History available since 17 May 2021. The latest transaction was filed on 31 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
81,433 shares@ US$3.0783.7% of flowCommon StockSEC:0001493152-25-000160:0
Ideal exit: 27 Sept 2025 (T+270)
7,751 shares@ US$6.1416.3% of flowCommon StockSEC:0001493152-22-023461:0
Ideal exit: 13 May 2023 (T+270)
9,492 shares@ US$5.3350.0% of flowCommon Stock, $$0.00001 par valueSEC:0001493152-21-012296
Ideal exit: 11 Feb 2022 (T+270)
9,492 shares@ US$5.3350.0% of flowCommon Stock, $$0.00001 par valueSEC:0001493152-21-012296:0
Ideal exit: 11 Feb 2022 (T+270)
4 of 4 declarations
About Duhay Francis
Francis Duhay is a Director at Hancock Jaffe Laboratories, Inc. In this role, he contributes to the governance and strategy of the company. Hancock Jaffe Laboratories, Inc. is a company specializing in the development of medical devices. Francis Duhay brings valuable expertise in medical technology and innovation.
